Companies › QNCX
QUINCE THERAPEUTICS (QNCX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001662774 · EDGAR filings · Updated 2026-06-26
QUINCE THERAPEUTICS (QNCX) has reported institutional ownership of 8.7%, with 40 institutional managers holding positions valued at $1.43M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-26 — Amended current report (8-K/A) filed
- 2026-06-26 — Current report (8-K) filed
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-11 — Insider transaction reported (Form 4)
- 2026-06-11 — Initial insider ownership filed (Form 3)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, QUINCE THERAPEUTICS has 40 institutional holders and institutional ownership of 8.7%.
Insider activity
Insiders reported 9 transactions (0 buys, 1 sells) across 4 reporting insiders, with a net reported value of −$173.5K.
Data flags from SEC filings
Related companies
PLUS THERAPEUTICS INC (PSTV) · Turn Therapeutics Inc (TTRX) · BioVie Inc (BIVI) · AMERICAN SHARED HOSPITAL SVC (AMS) · MINK THERAPEUTICS INC (INKT) · NUTRIBAND INC (NTRB)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-26.